Deep Dive/ R&D/ Views & Analysis/ Views and analysis Centessa’s founder on the new company’s unique R&D model mike.hammerton@pharmaphorum.com Centessa, Deep Dive, Francesco de Rubertis, Medicxi, R&D, Research and Development 2021 0 Comment Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted Share X Centessa’s founder on the new company’s unique R&D model https://pharmaphorum.com/r-d/views-analysis-r-d/centessa-founder-companys-unique-rd-model/